These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 37834415)
1. Antimicrobial Peptidomimetics Prevent the Development of Resistance against Gentamicin and Ciprofloxacin in Staphylococcus and Pseudomonas Bacteria. Browne K; Kuppusamy R; Walsh WR; Black DS; Willcox MDP; Kumar N; Chen R Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834415 [TBL] [Abstract][Full Text] [Related]
2. Coriander essential oil and linalool - interactions with antibiotics against Gram-positive and Gram-negative bacteria. Aelenei P; Rimbu CM; Guguianu E; Dimitriu G; Aprotosoaie AC; Brebu M; Horhogea CE; Miron A Lett Appl Microbiol; 2019 Feb; 68(2):156-164. PubMed ID: 30471142 [TBL] [Abstract][Full Text] [Related]
3. Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients. Feizi S; Cooksley CM; Nepal R; Psaltis AJ; Wormald PJ; Vreugde S Pathology; 2022 Jun; 54(4):453-459. PubMed ID: 34844745 [TBL] [Abstract][Full Text] [Related]
4. Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics. Baker KR; Jana B; Hansen AM; Nielsen HM; Franzyk H; Guardabassi L Front Cell Infect Microbiol; 2019; 9():236. PubMed ID: 31334131 [TBL] [Abstract][Full Text] [Related]
5. Novel antimony-based antimicrobial drug targets membranes of Gram-positive and Gram-negative bacterial pathogens. Salpadoru T; Pinks KE; Lieberman JA; Cotton K; Wozniak KL; Gerasimchuk N; Patrauchan MA Microbiol Spectr; 2024 Jun; 12(6):e0423423. PubMed ID: 38651882 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of distribution and drug resistance of pathogens of burn patients during 9 years]. Dou Y; Zhang Q Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):153-159. PubMed ID: 29609277 [No Abstract] [Full Text] [Related]
8. Synergistic antibacterial effects of exopolysaccharides/nickel-nanoparticles composites against multidrug-resistant bacteria. Garza-Cervantes JA; Mendiola-Garza G; León-Buitimea A; Morones-Ramírez JR Sci Rep; 2023 Dec; 13(1):21519. PubMed ID: 38057583 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of the Activity of Antibiotics against ATCC and MDR Bacterial Strains with (+)- Leite-Sampaio NF; Gondim CNFL; Martins RAA; Siyadatpanah A; Norouzi R; Kim B; Sobral-Souza CE; Gondim GEC; Ribeiro-Filho J; Coutinho HDM Biomed Res Int; 2022; 2022():8217380. PubMed ID: 35663042 [TBL] [Abstract][Full Text] [Related]
10. Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. Kastoris AC; Rafailidis PI; Vouloumanou EK; Gkegkes ID; Falagas ME Eur J Clin Pharmacol; 2010 Apr; 66(4):359-68. PubMed ID: 20186407 [TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents. Chin NX; Neu HC J Antimicrob Chemother; 1989 Mar; 23 Suppl C():95-101. PubMed ID: 2786520 [TBL] [Abstract][Full Text] [Related]
12. The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus. Kim W; Zou G; Pan W; Fricke N; Faizi HA; Kim SM; Khader R; Li S; Lee K; Escorba I; Vlahovska PM; Gao H; Ausubel FM; Mylonakis E mBio; 2020 Jun; 11(3):. PubMed ID: 32605985 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients]. Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922 [No Abstract] [Full Text] [Related]
14. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection]. Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068 [TBL] [Abstract][Full Text] [Related]
15. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Geitani R; Ayoub Moubareck C; Touqui L; Karam Sarkis D BMC Microbiol; 2019 Mar; 19(1):54. PubMed ID: 30849936 [TBL] [Abstract][Full Text] [Related]
16. New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity. Karine de Sousa A; Rocha JE; Gonçalves de Souza T; Sampaio de Freitas T; Ribeiro-Filho J; Melo Coutinho HD Microb Pathog; 2018 Oct; 123():368-371. PubMed ID: 30056107 [TBL] [Abstract][Full Text] [Related]
17. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001]. Yamaguchi K; Ishii Y; Iinuma Y; Yamanaka K; Ichiyama S; Watanabe N; Uehara N; Kaku M; Kurokawa Y; Hayashi M; Hirakata Y Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872 [TBL] [Abstract][Full Text] [Related]
18. Multi-drug resistant bacteria isolates from lymphatic filariasis patients in the Ahanta West District, Ghana. Aglomasa BC; Adu-Asiamah CK; Asiedu SO; Kini P; Amewu EKA; Boahen KG; Wireko S; Amponsah IK; Boakye YD; Boamah VE; Kwarteng A BMC Microbiol; 2022 Oct; 22(1):245. PubMed ID: 36221074 [TBL] [Abstract][Full Text] [Related]
19. Nano-ciprofloxacin/meropenem exhibit bactericidal activity against Gram-negative bacteria and rescue septic rat model. Hadiya S; Ibrahem RA; Abd El-Baky RM; Elsabahy M; Hussein AM; Tolba ME; Aly SA Nanomedicine (Lond); 2023 Sep; 18(22):1553-1566. PubMed ID: 37933674 [TBL] [Abstract][Full Text] [Related]